Literature DB >> 12748303

Role of SODD in regulation of tumor necrosis factor responses.

Hidetoshi Takada1, Nien-Jung Chen, Christine Mirtsos, Shinobu Suzuki, Nobutaka Suzuki, Andrew Wakeham, Tak W Mak, Wen-Chen Yeh.   

Abstract

Signaling from tumor necrosis factor receptor type 1 (TNFR1) can elicit potent inflammatory and cytotoxic responses that need to be properly regulated. It was suggested that the silencer of death domains (SODD) protein constitutively associates intracellularly with TNFR1 and inhibits the recruitment of cytoplasmic signaling proteins to TNFR1 to prevent spontaneous aggregation of the cytoplasmic death domains of TNFR1 molecules that are juxtaposed in the absence of ligand stimulation. In this study, we demonstrate that mice lacking SODD produce larger amounts of cytokines in response to in vivo TNF challenge. SODD-deficient macrophages and embryonic fibroblasts also show altered responses to TNF. TNF-induced activation of NF-kappaB is accelerated in SODD-deficient cells, but TNF-induced c-Jun N-terminal kinase activity is slightly repressed. Interestingly, the apoptotic arm of TNF signaling is not hyperresponsive in the SODD-deficient cells. Together, these results suggest that SODD is critical for the regulation of TNF signaling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12748303      PMCID: PMC155221          DOI: 10.1128/MCB.23.11.4026-4033.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  28 in total

Review 1.  The TNF and TNF receptor superfamilies: integrating mammalian biology.

Authors:  R M Locksley; N Killeen; M J Lenardo
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

2.  A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling.

Authors:  F K Chan; H J Chun; L Zheng; R M Siegel; K L Bui; M J Lenardo
Journal:  Science       Date:  2000-06-30       Impact factor: 47.728

3.  Tumor necrosis factor receptor 1 is an ATPase regulated by silencer of death domain.

Authors:  Kiyoshi Miki; Edward M Eddy
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

4.  Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling.

Authors:  E De Smaele; F Zazzeroni; S Papa; D U Nguyen; R Jin; J Jones; R Cong; G Franzoso
Journal:  Nature       Date:  2001-11-15       Impact factor: 49.962

5.  Inhibition of JNK activation through NF-kappaB target genes.

Authors:  G Tang; Y Minemoto; B Dibling; N H Purcell; Z Li; M Karin; A Lin
Journal:  Nature       Date:  2001-11-15       Impact factor: 49.962

6.  DR3 regulates negative selection during thymocyte development.

Authors:  E C Wang; A Thern; A Denzel; J Kitson; S N Farrow; M J Owen
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

Review 7.  TNF alpha and the TNF receptor superfamily: structure-function relationship(s).

Authors:  H T Idriss; J H Naismith
Journal:  Microsc Res Tech       Date:  2000-08-01       Impact factor: 2.769

8.  Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice.

Authors:  E G Lee; D L Boone; S Chai; S L Libby; M Chien; J P Lodolce; A Ma
Journal:  Science       Date:  2000-09-29       Impact factor: 47.728

9.  TRAF1 is a negative regulator of TNF signaling. enhanced TNF signaling in TRAF1-deficient mice.

Authors:  E N Tsitsikov; D Laouini; I F Dunn; T Y Sannikova; L Davidson; F W Alt; R S Geha
Journal:  Immunity       Date:  2001-10       Impact factor: 31.745

10.  The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN.

Authors:  K Heyninck; D De Valck; W Vanden Berghe; W Van Criekinge; R Contreras; W Fiers; G Haegeman; R Beyaert
Journal:  J Cell Biol       Date:  1999-06-28       Impact factor: 10.539

View more
  19 in total

1.  Mechanistic insight into the ability of American ginseng to suppress colon cancer associated with colitis.

Authors:  Xiangli Cui; Yu Jin; Deepak Poudyal; Alexander A Chumanevich; Tia Davis; Anthony Windust; Anne Hofseth; Wensong Wu; Joshua Habiger; Edsel Pena; Patricia Wood; Mitzi Nagarkatti; Prakash S Nagarkatti; Lorne Hofseth
Journal:  Carcinogenesis       Date:  2010-08-20       Impact factor: 4.944

2.  The PI3K/mTOR dual inhibitor BEZ235 suppresses proliferation and migration and reverses multidrug resistance in acute myeloid leukemia.

Authors:  Lan Deng; Ling Jiang; Xiang-Hua Lin; Kuo-Fu Tseng; Yuan Liu; Xing Zhang; Rui-Hong Dong; Zhi-Gang Lu; Xiu-Ju Wang
Journal:  Acta Pharmacol Sin       Date:  2017-01-02       Impact factor: 6.150

3.  Silencer of death domains (SODD) inhibits skeletal muscle and kidney enriched inositol 5-phosphatase (SKIP) and regulates phosphoinositide 3-kinase (PI3K)/Akt signaling to the actin cytoskeleton.

Authors:  Parvin Rahman; Richard D Huysmans; Fenny Wiradjaja; Rajendra Gurung; Lisa M Ooms; David A Sheffield; Jennifer M Dyson; Meredith J Layton; Absorn Sriratana; Hidetoshi Takada; Tony Tiganis; Christina A Mitchell
Journal:  J Biol Chem       Date:  2011-06-28       Impact factor: 5.157

4.  BAG3 and Hsc70 interact with actin capping protein CapZ to maintain myofibrillar integrity under mechanical stress.

Authors:  Akinori Hishiya; Toshio Kitazawa; Shinichi Takayama
Journal:  Circ Res       Date:  2010-09-30       Impact factor: 17.367

5.  Fas-associated protein with death domain (FADD)-independent recruitment of c-FLIPL to death receptor 5.

Authors:  Tai-Guang Jin; Alexei Kurakin; Nordine Benhaga; Karon Abe; Mehrdad Mohseni; Ferry Sandra; Keli Song; Brian K Kay; Roya Khosravi-Far
Journal:  J Biol Chem       Date:  2004-10-14       Impact factor: 5.157

6.  Axotomy-induced target disconnection promotes an additional death mechanism involved in motoneuron degeneration in amyotrophic lateral sclerosis transgenic mice.

Authors:  Melissa M Haulcomb; Nichole A Mesnard; Richard J Batka; Thomas D Alexander; Virginia M Sanders; Kathryn J Jones
Journal:  J Comp Neurol       Date:  2014-07-01       Impact factor: 3.215

7.  Expression of SODD and P65 in ALL of children and its relationship with chemotherapeutic drugs.

Authors:  Hongfang Tao; Qun Hu; Jianlin Fang; Aiguo Liu; Shuangyou Liu; Liuqing Zhang; Ying Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-06

Review 8.  A multi-targeted approach to suppress tumor-promoting inflammation.

Authors:  Abbas K Samadi; Alan Bilsland; Alexandros G Georgakilas; Amedeo Amedei; Amr Amin; Anupam Bishayee; Asfar S Azmi; Bal L Lokeshwar; Brendan Grue; Carolina Panis; Chandra S Boosani; Deepak Poudyal; Diana M Stafforini; Dipita Bhakta; Elena Niccolai; Gunjan Guha; H P Vasantha Rupasinghe; Hiromasa Fujii; Kanya Honoki; Kapil Mehta; Katia Aquilano; Leroy Lowe; Lorne J Hofseth; Luigi Ricciardiello; Maria Rosa Ciriolo; Neetu Singh; Richard L Whelan; Rupesh Chaturvedi; S Salman Ashraf; H M C Shantha Kumara; Somaira Nowsheen; Sulma I Mohammed; W Nicol Keith; William G Helferich; Xujuan Yang
Journal:  Semin Cancer Biol       Date:  2015-05-05       Impact factor: 15.707

9.  BAG3 directly interacts with mutated alphaB-crystallin to suppress its aggregation and toxicity.

Authors:  Akinori Hishiya; Mortada Najem Salman; Serena Carra; Harm H Kampinga; Shinichi Takayama
Journal:  PLoS One       Date:  2011-03-15       Impact factor: 3.240

10.  Inflammatory cytokines in maternal circulation and placenta of chromosomally abnormal first trimester miscarriages.

Authors:  Jean Calleja-Agius; Eric Jauniaux; Shanthi Muttukrishna
Journal:  Clin Dev Immunol       Date:  2011-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.